Two MOLIT contributions selected for Best of Congress at DGHO 2019
Two scientific contributions from the MOLIT Institute were selected and presented in the Best of Congress session at the DGHO Annual Meeting 2019 in Berlin:
- Platinum-based chemotherapy prolongs survival in pancreatic cancer patients with germline mutations in BRCAness genes
- Impact of NGS panel size on potential therapy options in metastatic colorectal cancer
In total, MOLIT was represented with six presentations at the DGHO.
The Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology (DGHO)is the most important scientific congress in the German-speaking world for this field, attracting more than 6,000 participants.